September 13, 2016
By Christopher Florentz
This summer’s World Federation of Hemophilia Congress got off to a fast start with CSL Behring’s coagulation team eager to meet with patients and healthcare providers and discuss their needs and how we can meet them.
The level of excitement among the CSL Behring’s team was palpable, as CSL CEO and Managing Director Paul Perreault kicked things off at the start of the Congress by reinforcing to them the importance of maintaining focus on what matters most:
“If we think about patients every day and do the right things for them, the rest will take care of itself. We began with the promise to produce much needed medicines for the people of Australia. Today we are bringing medicines to the world.”